Literature DB >> 25663502

Ischemic stroke in pediatric moyamoya disease associated with immune thrombocytopenia--a case report.

Tomohide Hayashi1, Naoki Akioka, Daina Kashiwazaki, Naoya Kuwayama, Satoshi Kuroda.   

Abstract

CASE REPORT: A 10-year-old boy developed refractory bleeding and was diagnosed with immune thrombocytopenia (ITP). He was treated with steroids and intravenous immunoglobulin (IVIG). Five months later, however, he developed right homonymous hemianopsia, sensory aphasia, agraphia, and agnosia. MR imaging demonstrated multiple cerebral infarction in the bilateral cerebral hemispheres, and MR angiography revealed severe stenosis of the bilateral internal carotid arteries. He was diagnosed with moyamoya disease and successfully underwent surgical revascularization on both sides under IVIG therapy. However, multiple cerebral infarcts developed in the bilateral cerebral hemispheres 10 days after the second surgical revascularization when platelet counts were within normal limits. Furthermore, chronic subdural hematoma gradually increased in size after each surgery, which required burr hole surgery to resolve increased intracranial pressure, when platelet counts decreased to less than 10 × 10(9)/L.
CONCLUSION: This is the first report presenting a case with moyamoya disease coincident with ITP. Critical managements would be essential to reduce perioperative complications, because ITP is known to provoke both hemorrhagic and ischemic events through multiple mechanisms.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25663502     DOI: 10.1007/s00381-015-2619-4

Source DB:  PubMed          Journal:  Childs Nerv Syst        ISSN: 0256-7040            Impact factor:   1.475


  25 in total

1.  Suppression of in vitro megakaryocyte production by antiplatelet autoantibodies from adult patients with chronic ITP.

Authors:  Robert McMillan; Lei Wang; Aaron Tomer; Janet Nichol; Jeanne Pistillo
Journal:  Blood       Date:  2003-10-23       Impact factor: 22.113

2.  Idiopathic thrombocytopenic purpura in childhood: twenty years of experience in a single center.

Authors:  Eftichia Stiakaki; Chryssoula Perdikogianni; Christina Thomou; Erasmia-Athina Markaki; Nikolaos Katzilakis; Maria Tsirigotaki; Maria Kalmanti
Journal:  Pediatr Int       Date:  2012-05-30       Impact factor: 1.524

Review 3.  Moyamoya disease: current concepts and future perspectives.

Authors:  Satoshi Kuroda; Kiyohiro Houkin
Journal:  Lancet Neurol       Date:  2008-11       Impact factor: 44.182

4.  Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group.

Authors:  Francesco Rodeghiero; Roberto Stasi; Terry Gernsheimer; Marc Michel; Drew Provan; Donald M Arnold; James B Bussel; Douglas B Cines; Beng H Chong; Nichola Cooper; Bertrand Godeau; Klaus Lechner; Maria Gabriella Mazzucconi; Robert McMillan; Miguel A Sanz; Paul Imbach; Victor Blanchette; Thomas Kühne; Marco Ruggeri; James N George
Journal:  Blood       Date:  2008-11-12       Impact factor: 22.113

5.  Acute cerebellar infarction associated with intravenous gammaglobulin treatment in idiopathic thrombocytopenic purpura.

Authors:  Woo-Joo Choi; Min-Jee Kim; Chulho Kim; Jong Hee Sohn; Hui-Chul Choi
Journal:  J Stroke Cerebrovasc Dis       Date:  2012-06-29       Impact factor: 2.136

6.  Clinical significance of platelet microparticles in autoimmune thrombocytopenias.

Authors:  W Jy; L L Horstman; M Arce; Y S Ahn
Journal:  J Lab Clin Med       Date:  1992-04

7.  Recurrent ischemic stroke in a patient with idiopathic thrombocytopenic purpura.

Authors:  Hak Young Rhee; Hye-Yeon Choi; Sang-Beom Kim; Won-Chul Shin
Journal:  J Thromb Thrombolysis       Date:  2010-08       Impact factor: 2.300

8.  Prospective screening of 205 patients with ITP, including diagnosis, serological markers, and the relationship between platelet counts, endogenous thrombopoietin, and circulating antithrombopoietin antibodies.

Authors:  Louis M Aledort; Catherine P M Hayward; Mon-Gy Chen; Janet L Nichol; James Bussel
Journal:  Am J Hematol       Date:  2004-07       Impact factor: 10.047

9.  Reversible encephalopathy with cerebral vasospasm in a Guillain-Barré syndrome patient treated with intravenous immunoglobulin.

Authors:  R Voltz; F V Rosen; T Yousry; J Beck; R Hohlfeld
Journal:  Neurology       Date:  1996-01       Impact factor: 9.910

10.  Multivessel coronary thrombosis in a patient with idiopathic thrombocytopenic purpura.

Authors:  Julide Yagmur; Mehmet Cansel; Nusret Acikgoz; Murat Yagmur; Ferhat Eyupkoca; Necip Ermis; Erdal Akturk
Journal:  Tex Heart Inst J       Date:  2012
View more
  2 in total

1.  Moyamoya-like vasculopathy associated to MYH9-related thrombocytopenia manifested by multiple cerebral ischemic lesions: a case report.

Authors:  Athena Cristina Ribigan; Raluca Stefania Badea; Alida Ciocan; Dana Stefan; Bogdan Casaru; Patricia Ioan; Florina Antochi; Ovidiu Băjenaru
Journal:  BMC Neurol       Date:  2020-09-19       Impact factor: 2.474

Review 2.  Progression in Moyamoya Disease: Clinical Features, Neuroimaging Evaluation, and Treatment.

Authors:  Xin Zhang; Weiping Xiao; Qing Zhang; Ding Xia; Peng Gao; Jiabin Su; Heng Yang; Xinjie Gao; Wei Ni; Yu Lei; Yuxiang Gu
Journal:  Curr Neuropharmacol       Date:  2022       Impact factor: 7.708

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.